FDMT
NASDAQ · Biotechnology
4D Molecular Therapeutics In
$12.25
+1.00 (+8.89%)
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Price Target
Analyst Price Target
+72.3% upside
Low Target
$12.84
Average Target
$21.11
High Target
$26.25
Current Price
$12.25
Current
$12.25
$12.25
Target
$21.11
$21.11
$12.84
$21.11 avg
$26.25
Scenario Analysis
Bear Case
$12.84
4.8%
Low target
Base Case
$21.11
+72.3%
Avg target
Bull Case
$26.25
+114.3%
High target
Risk/Reward
23.7x
Highly favorable
Price in Context
52-Week High
$16.93
-27.6% from high
52-Week Low
$6.96
+76.0% from low
Target vs 52W High
$21.11
+24.7% vs high
Next Earnings Report
Nov 11, 2026
Today
EPS Est: $-1.07
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.4% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.8% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +113.5% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -20.3% |
| MRNA | Hold | 31 | 32% | $149.45 | -42.1% |
| REGN | Buy | 36 | 72% | $76.80 | -91.6% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -54.5% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -40.3% |